Medicinal Cannabis Eases Endometriosis and Pelvic Pain
Medicinal cannabis endometriosis pain relief is gaining attention for its potential to ease pelvic pain symptoms. Emerging evidence suggests cannabinoids may modulate inflammatory and neurobiological pathways involved in endometriosis. However, clinical…
New Research Suggests Cannabis May Improve Women’s Sexual Health
Emerging research highlights cannabis sexual health benefits for women, suggesting potential improvements in sexual function and intimacy. Clinicians should be aware of these findings to provide informed counseling. Understanding cannabis's role in…
House Passes Bill to Ease Access to Georgia’s Medical Cannabis Program
The new medical cannabis program bill in Georgia aims to ease patient access by reducing regulatory barriers. This streamlined access could increase patient requests for cannabis recommendations. Clinicians should familiarize themselves with the updated…
Marijuana – Point of View
Cannabis safety research is essential for clinicians to provide informed counseling about cannabis risks. Emerging evidence highlights the importance of understanding adverse effects. This research supports balanced clinical guidance on cannabis use.
The Impact of Rescheduling Cannabis on Federal Research Changes
Rescheduling cannabis research federal changes remove significant barriers to clinical trials. This shift enables physicians to rely on evidence-based data for prescribing decisions. It marks a critical move toward advancing patient care and expanding…
CBD and CBG: Promising Treatments for Fatty Liver Disease
A new CBD and CBG fatty liver disease study highlights promising therapeutic potential for metabolic liver conditions. These cannabinoids may reduce liver fat and improve metabolic health. This study offers hope for new treatment options beyond lifestyle…
Study Suggests CBD and CBG Could Be Treatment for Chronic Liver Disease
Recent research highlights the cannabigerol therapeutic potential review for chronic liver disease. CBD and CBG show promise in addressing fatty liver disease. These findings may expand treatment options for millions affected.
Federal Marijuana Rescheduling May Speed Tennessee MMJ Legalization
Federal marijuana rescheduling Tennessee medical cannabis could remove barriers to clinical research and accelerate legalization in Tennessee. This shift allows clinicians to access evidence-based data for patient care. It also enables a legal framework…
Recreational Cannabis Laws May Displace Illegal Cannabis Markets
Research on recreational cannabis legalization impacts provides key insights into illegal market displacement. Legal markets may reduce reliance on unregulated cannabis sources, improving patient safety. Understanding these dynamics is crucial for…
The Cannabis Mental Health Evidence Gap: Association vs. Causation
The cannabis mental health evidence gap highlights the challenges in distinguishing association from causation in cognitive decline studies. Current research shows no clear link between cannabis use and dementia risk in older adults. Clinicians must…